SARAH ORCIUCH: Open Payments
NPI 1285065144 · NORTH FALMOUTH, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,268 in 145 payments from 14 companies in 2025. Trend: 2023 $2,441 · 2024 $2,443 · 2025 $2,268
Food & beverage: $2,163Education: $105
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 26 | $524 |
| ABBVIE INC. | 71 | $516 |
| GENZYME CORPORATION | 6 | $177 |
| Novartis Pharmaceuticals Corporation | 6 | $173 |
| UCB, Inc. | 8 | $168 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $160 |
| E.R. Squibb & Sons, L.L.C. | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 3 | $93 |
| LEO Pharma Inc. | 3 | $83 |
| Amgen Inc. | 3 | $77 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, Bimzelx, RINVOQ, ILUMYA, Sotyktu, Otezla.
Industry payments across MA — which companies pay providers there.
